Prestigious Prize Honors Pioneering Body's Defenses Research
This year's Nobel Prize in medical science has been granted for revolutionary discoveries that illuminate how the immune system targets harmful infections while protecting the healthy tissues.
Three renowned researchers—Japan's Shimon Sakaguchi and US experts Mary Brunkow and Dr. Ramsdell—share this accolade.
The work identified specialized "sentinels" within the defense system that eliminate rogue immune cells that could attacking the organism.
The findings are now paving the way for innovative treatments for immune disorders and cancer.
The winners will divide a monetary award worth 11 million Swedish kronor.
Crucial Findings
"Their work has been essential for comprehending how the body's defenses operates and the reason we do not all develop severe self-attack conditions," stated the head of the award panel.
This trio's research explain a core mystery: How does the defense system protect us from numerous infections while keeping our own tissues unharmed?
The immune system uses white blood cells that scan for signs of disease, including pathogens and germs it has never encountered.
Such cells utilize detectors—called recognition units—that are produced by chance in a vast number of variations.
This provides the defense network the capacity to combat a broad range of threats, but the randomness of the mechanism unavoidably creates immune cells that may attack the body.
Protectors of the Immune System
Researchers previously understood that some of these harmful defense cells were eliminated in the immune organ—the site where immune cells develop.
The latest award recognizes the discovery of T-reg cells—described as the body's "peacekeepers"—which travel through the system to disarm other defenders that assault the healthy cells.
We know that this process malfunctions in self-attack conditions such as type-1 diabetes, MS, and rheumatoid arthritis.
A prize committee stated, "These findings have established a new field of research and accelerated the development of innovative treatments, for example for tumors and immune disorders."
Regarding malignancies, T-regs block the system from fighting the tumor, so studies are focused on reducing their quantity.
In self-attack disorders, trials are testing increasing T-reg cells so the body is no longer under attack. A comparable approach could also be useful in reducing the risks of transplanted organ failure.
Innovative Experiments
Professor Shimon Sakaguchi, of a Japanese institution, conducted experiments on rodents that had their thymus extracted, causing autoimmune disease.
The researcher showed that introducing immune cells from other mice could prevent the illness—suggesting there was a system for preventing defenders from harming the body.
Dr. Brunkow, from the Institute for Systems Biology in Seattle, and Dr. Ramsdell, currently at a biotech firm in a California city, were investigating an genetic immune disorder in mice and humans that led to the identification of a genetic factor vital for how regulatory T-cells function.
"Their pioneering research has revealed how the body's defenses is kept in check by T-reg cells, preventing it from mistakenly targeting the healthy cells," said a leading physiology specialist.
"The work is a remarkable illustration of how basic biological research can have far-reaching implications for public health."